Literature DB >> 32233641

Network pharmacology-based analysis of the role of traditional Chinese herbal medicines in the treatment of COVID-19.

Shengwei Yu1, Junwu Wang1, Haitao Shen2.   

Abstract

BACKGROUND: The novel coronavirus named COVID-19, which originated in Wuhan, China, has spread to many countries around the world. Currently, no effective medical treatment exists to combat this disease. Traditional Chinese herbal medicines (CHM) have unique roles in the treatment of viral infections. In this article we analyzed the effectiveness and possible molecular mechanisms of CHM formulas for the prevention of COVID-19.
METHODS: The active ingredients and action targets of CHM formulas were obtained from the TCMSP database. Genes related to severe acute respiratory syndromes (SARS) and Middle East respiratory syndrome (MERS) were queried on the GeneCards database. The action mechanisms of these genes were predicted using a Gene Ontology (GO)-based functional enrichment and annotation tool and the Kyoto Encyclopedia of Genes and Genomes (KEGG).
RESULTS: CHM formulas played a positive role in preventing COVID-19 and warrant further application.
CONCLUSIONS: Our research provides new evidence to support the possible value of CHM formulas for the prevention of COVID-19. However, further clinical studies with large sample sizes are required to verify their effectiveness.

Entities:  

Keywords:  COVID-19; Novel coronavirus; network pharmacology; traditional Chinese herbal medicines (traditional CHM)

Mesh:

Year:  2020        PMID: 32233641     DOI: 10.21037/apm.2020.03.27

Source DB:  PubMed          Journal:  Ann Palliat Med        ISSN: 2224-5820


  14 in total

1.  Mechanism of Thunberg Fritillaria in treating endometriosis based on network pharmacology and the effect of Peiminine on the MEK/ERK pathway.

Authors:  Xia Peng; Yue Xia; Jiani Xie; Honglin Liu; Limin Fan; Chaoqin Yu; Xiaorong Ni
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

2.  Chinese Medicine Meets Conventional Medicine in Targeting COVID-19 Pathophysiology, Complications and Comorbidities.

Authors:  Shan-Shan Wang; Xian Zeng; Ya-Li Wang; Zhuoma Dongzhi; Yu-Fen Zhao; Yu-Zong Chen
Journal:  Chin J Integr Med       Date:  2022-05-18       Impact factor: 2.626

Review 3.  Phytomolecules Repurposed as Covid-19 Inhibitors: Opportunity and Challenges.

Authors:  Vaishnavi Chandramouli; Shekhar Kumar Niraj; Krishna G Nair; Jerrine Joseph; Wilson Aruni
Journal:  Curr Microbiol       Date:  2021-08-26       Impact factor: 2.343

4.  Deciphering the co-adaptation of codon usage between respiratory coronaviruses and their human host uncovers candidate therapeutics for COVID-19.

Authors:  Komi Nambou; Manawa Anakpa
Journal:  Infect Genet Evol       Date:  2020-07-22       Impact factor: 3.342

Review 5.  The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19.

Authors:  Xuedong An; YueHong Zhang; Liyun Duan; Shenghui Zhao; RongRong Zhou; Yingying Duan; Fengmei Lian; Xiaolin Tong
Journal:  Biomed Pharmacother       Date:  2021-01-14       Impact factor: 7.419

6.  Integrating Network Pharmacology and Experimental Validation to Investigate the Mechanisms of Huazhuojiedu Decoction to Treat Chronic Atrophic Gastritis.

Authors:  Xinyu Hao; Yu Liu; Pingping Zhou; Qian Jiang; Zeqi Yang; Miaochan Xu; Shaowei Liu; Shixiong Zhang; Yangang Wang
Journal:  Evid Based Complement Alternat Med       Date:  2020-12-07       Impact factor: 2.629

Review 7.  Drug repurposing against coronavirus disease 2019 (COVID-19): A review.

Authors:  Lianxiang Luo; Qin Qiu; Fangfang Huang; Kaifeng Liu; Yongqi Lan; Xiaoling Li; Yuge Huang; Liao Cui; Hui Luo
Journal:  J Pharm Anal       Date:  2021-09-04

8.  Integrated Network Pharmacology and Mice Model to Investigate Qing Zao Fang for Treating Sjögren's Syndrome.

Authors:  Ping Zeng; Wei Liu; Shumin Zhang; Shaopeng Du; Yihua Fan; Longmei Zhao; Aihua Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-10       Impact factor: 2.629

Review 9.  Progress in the diagnosis and treatment of COVID-19 and the role of surgeons in the front line of the pandemic.

Authors:  Yun-Jie Shi; Hao Wang
Journal:  Surg Today       Date:  2020-09-04       Impact factor: 2.549

Review 10.  An Update on Current Therapeutic Drugs Treating COVID-19.

Authors:  Renyi Wu; Lujing Wang; Hsiao-Chen Dina Kuo; Ahmad Shannar; Rebecca Peter; Pochung Jordan Chou; Shanyi Li; Rasika Hudlikar; Xia Liu; Zhigang Liu; George J Poiani; Louis Amorosa; Luigi Brunetti; Ah-Ng Kong
Journal:  Curr Pharmacol Rep       Date:  2020-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.